Idenix Pharmaceuticals Inc

Latest Idenix Pharmaceuticals Inc News and Updates

  • Healthcare

    The Baupost Group ups its stake in Idenix Pharmaceuticals

    Idenix Pharmaceuticals (IDIX) accounted for a 6.25% position in Baupost’s fourth quarter portfolio. The hedge fund increased its stock holdings in Idenix last month.

    By Samantha Nielson
  • Energy & Utilities

    Must-know highlights of the Baupost Group’s 1Q 2014 positions

    Seth Klarman’s Baupost Group, LLC, returned $4 billion to clients at the end of last year. The fund is one of the best-performing hedge fund managers of all time, generating $21.5 billion in returns over its history.

    By Samantha Nielson
  • Energy & Utilities

    Seth Klarman’s Baupost Group raises its stake in PBF Energy

    The Baupost Group raised its stake in PBF Energy Inc. (PBF) by 1,021,466 shares to own 1,976,606 shares at the end of the fourth quarter.

    By Samantha Nielson
  • Energy & Utilities

    Seth Klarman’s Baupost Group buys stake in Kindred Biosciences

    The Baupost Group opened a new position in animal health company Kindred Biosciences Inc. (KIN) that accounts for 0.92% of the fund’s $3.5 billion portfolio.

    By Samantha Nielson
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.